Patents for A61P 19 - Drugs for skeletal disorders (81,981)
09/2010
09/09/2010DE112008001609T5 Reparatur und Behandlung von Knochendefekten unter Verwendung von mittels einem Wirkstoff induzierten Zellen, der von hypertrophierungsfähigen Chondrozyten hergestellt wird, und eines Gerüsts Repair and treat bone defects using an active substance-induced cells, which is manufactured by hypertrophierungsfähigen chondrocytes, and a scaffold
09/08/2010EP2226632A1 Method for screening of cell-protecting agent
09/08/2010EP2226324A1 Beta-amino tetrahydroimidazo(1,2-a)pyrazines and tetrahydrotriazolo(4,3-a)pyrazines for use in the treatment of diabetes type ii
09/08/2010EP2226323A1 New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives
09/08/2010EP2226315A1 2-aminoquinazoline derivative
09/08/2010EP2225252A1 C2-c5-alkyl-imidazole-bisphosphonates
09/08/2010EP2225245A2 N-phenyl-imidazoý1,2-a¨pyridine-2-carboxamide compounds, preparation thereof and therapeutic application thereof
09/08/2010EP2225244A1 Imidazoý1,2-a¨pyridine-2-carboxamide derivatives, preparation thereof and application thereof in therapeutics
09/08/2010EP2225243A2 Derivatives of n-heterocyclic-6-heterocyclic-imidazoýl,2- a¨pyridine-2-carboxamides, preparation thereof and therapeutic application thereof
09/08/2010EP2225242A2 Derivatives of n-heterocyclic-imidazoý1,2-a¨pyridine-2-carboxamides, preparation thereof and therapeutic application thereof
09/08/2010EP2225241A2 Derivatives of n-phenyl-imidazoý1,2-a¨pyridine-2-carboxamides, preparation thereof and therapeutic application thereof
09/08/2010EP2225240A2 Derivatives of 6-heterocyclic-imidazoýl,2-a¨pyrroine-2-carboxamides, preparation thereof and therapeutic application thereof
09/08/2010EP2225227A2 Compounds
09/08/2010EP2225223A2 Organic compounds
09/08/2010EP2225222A1 A quinoline derivative acting as a p2x7-receptor antagonist
09/08/2010EP2224955A1 14-3-3 antagonists for the prevention and treatment of arthritis
09/08/2010EP2224939A2 Preparations with rosehip extracts, and method of producing rosehip extracts
09/08/2010EP1807431B1 Pyrrolo[1,2-d][1,2-4]triazine as inhibitors of c-jun n-terminal kinases (jnk) and p-38 kinases
09/08/2010EP1521839B1 Methods of making viral particles having a modified cell binding activity and uses thereof
09/08/2010EP1478624B1 Chemical compounds
09/08/2010EP1412374B1 Novel pgc-1 isoforms and uses therefor
09/08/2010EP1320531B1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
09/08/2010EP1263759B1 Azaindoles
09/08/2010CN1942581B Antibody with osteoclast-related protein as target
09/08/2010CN1659144B Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
09/08/2010CN101827844A Imidazo [1,2-a] pyridine derivatives useful as ALK inhibitors
09/08/2010CN101827603A Methods of generating, repairing and/or maintaining connective tissue in vivo
09/08/2010CN101824424A DNA vaccine based on B7-2-PE40 exotoxin fusion gene and application thereof
09/08/2010CN101824087A Glucagon-like peptide-2 analog as well as preparation method and application thereof
09/08/2010CN101823964A Technology for preparing chlorogenic acid in viburnum sargentii koehne leaves
09/08/2010CN101822798A Method for preparing tiger-bone wine
09/08/2010CN101822797A Preparation method of medicament for treating hyperosteogeny
09/08/2010CN101822784A Plaster for treating spur and preparation method thereof
09/08/2010CN101822767A External plaster for treating sclerotin and osseous nerve diseases
09/08/2010CN101822765A Quality inspection method of traditional Chinese medicine compound preparation with functions of tonifying kidney, strengthening bones, enriching blood and being beneficial to sperm
09/08/2010CN101822763A Chuanlongguci capsule and preparation method thereof
09/08/2010CN101822759A Quality testing method of plaster for treating fracture and soft tissue injury
09/08/2010CN101822732A Traditional Chinese medicinal preparation for treating pain and numbness of limbs
09/08/2010CN101822723A Method for measuring content of components of prince's-feather herb
09/08/2010CN101822695A Complex bone peptide injection and preparation method of complex bone peptide for injection
09/08/2010CN101822689A Medicament compound containing hyaluronic acid and beta-aescine sodium
09/08/2010CN101822688A Compound tylosin injection for animals and preparation method thereof
09/08/2010CN101822687A Use of hesperidine or one of its derivatives for making a medicine for bone formation stimulation
09/08/2010CN101822684A Compound combined preparation for preventing osteoarticular pain and preparation method thereof
09/08/2010CN101822670A Application of berberine in preparing medicament for preventing and treating rheumatoid arthritis
09/08/2010CN101822658A Cysteamines for treating complications of hypercholesterolemia and diabetes
09/08/2010CN101822645A Controlled-release recombinant human bone morphogenic protein-2 poly-L-lactic acid microspheres and preparation method thereof
09/08/2010CN101386605B Febustat novel crystal and preparation method thereof
09/08/2010CN101301407B Medicament for treating arthritis and angiitis
09/08/2010CN101284097B Plaster for curing the protrusion of lumbar intervertebral discs, hyperosteogeny and rheumatoid and preparation method thereof
09/08/2010CN101214291B Externally-applied medicine for treating cervical and lumbar diseases without operation
09/08/2010CN101204566B Peroral Chinese traditional medicine composite for hyperosteogeny in knee joint
09/08/2010CN101185730B Ache relieving mixture for treating urarthritis
09/08/2010CN101185672B Orally-administered traditional Chinese medicine decoction for treating lumbar hyperosteogeny
09/08/2010CN101181444B Multi-efficacy externally used drug as well as method for preparing immersion agent thereof
09/08/2010CN101152349B Multifunctional health care medical pillow and its preparing process
09/08/2010CN101080403B Novel hydantoin derivatives as metalloproteinase inhibitors
09/08/2010CN101032569B Medicine drink good for spine
09/08/2010CN101014329B Pharmaceutical composition for preventing or treating rejection reaction of organ or tissue transplant, host resistance reaction of implant in bone marrow transplantation
09/07/2010US7790916 therapy of NF-kappaB mediated diseases; mitochondrial diseases; transplantation medicine
09/07/2010US7790853 Determination of bone-sialoprotein in bodily fluids for oncological problems
09/07/2010US7790851 heterodimeric receptor complex comprising an isolated soluble cytokine receptor and a soluble zcytor11 polypeptide; for use in treatment of cell proliferative, inflammatory and immune disorders
09/07/2010US7790764 Biologically active macrolides, compositions, and uses thereof
09/07/2010US7790736 Dipeptidyl peptidase inhibitors
09/07/2010US7790723 1-[3-(3-cyclopentyloxy-4-methoxyphenyl)-3,4,5,6-tetrahydropyridazin-1-yl]-1-[4-methyl-2-(1-oxypyridin-2-yl)thiazol-5-yl]methanone, used for inhibiting proliferation of lymphocytes in a host, and for the treatment of osteoporosis, tumors, cachexia, atherosclerosis, arthritis, multiple sclerosis, diabetes
09/07/2010US7790713 Inhibitors of interleukin-1β converting enzyme
09/07/2010US7790703 New phosphonate ester derivatives of purine or pyrimidine antivirals; side effect reduction, less toxic, bioavailability
09/07/2010US7790692 Improving tissue survival; methods for enhancing organ transplant, musculocutaneous flap or skin graft survival by administering a nucleic acid sequence encoding hepatocyte growth factor; neovascularization; surgery; tissue-targeted therapy
09/07/2010US7790684 Method of inhibiting osteoclast activity
09/07/2010US7790674 Treating inflammatory disease; use in combination with other antiinflammatory agents such as anakinra; rheumatoid arthritis for example; Ang-2 inhibitor peptides of amino acid sequence WDPWT
09/07/2010US7790158 Using tumor necrosis factors specific immunoglobulins to treat rheumatoid arthritis, diabetes type I, multiple sclerosis, and inflammatory bowel diseases
09/07/2010US7789841 Method and apparatus for connective tissue treatment
09/07/2010CA2512193C 3-(3,5-dioxo-4,5-dihydro-3h-(1,2,4)triazin-2-yl)-benzamide derivatives as p2x7-inhibitors for the treatment of inflammatory diseases
09/07/2010CA2493680C Condensed heterocyclic pyrazole derivatives as kinase inhibitors
09/07/2010CA2368676C Sphingomyelin containing preparation
09/07/2010CA2259156C Truncated soluble tumor necrosis factor type-i and type-ii receptors
09/07/2010CA2226177C Analogs of parathyroid hormone
09/02/2010WO2010098609A2 Composition for preventing and treating bone disease
09/02/2010WO2010098428A1 Process for producing phenyl-substituted heterocyclic derivative through coupling using transition metal catalyst
09/02/2010WO2010098421A1 Recombinant human bone morphogenetic protein having improved storage stability
09/02/2010WO2010098396A1 Process for producing phenyl-substituted heterocyclic derivative
09/02/2010WO2010098298A1 Pharmaceutical composition comprising combination of compound having nutrient digestion/absorption inhibitory activity and cyclohexanecarboxamide derivative
09/02/2010WO2010098265A1 Polymeric micelle containing proteasome inhibitor
09/02/2010WO2010097334A1 Drug combinations containing pde4 inhibitors and nsaids
09/02/2010WO2010097332A1 Drug combinations containing pde4 inhibitors and nsaids
09/02/2010WO2010097172A1 New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives
09/02/2010WO2010036497A3 Selective estrogen repector modulator for the treatment of osteoarthritis
09/02/2010US20100222591 New Compounds
09/02/2010US20100222438 Methods compositions and article of manufacture for modulating bone growth
09/02/2010US20100222419 Method to inhibit cell growth using oligonucleotides
09/02/2010US20100222366 Piperidine derivatives as modulators of chemokine receptor activity
09/02/2010US20100222363 Bicyclic Derivatives as P38 Inhibitors
09/02/2010US20100222348 Quinolinone derivatives as parp inhibitors
09/02/2010US20100222340 SUBSTITUTED PYRIDO [1,2-a] ISOQUINOLINE DERIVATIVES
09/02/2010US20100222316 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
09/02/2010US20100222311 Solid formulations of crystalline compounds
09/02/2010US20100222303 Reverse-turn mimetics and method relating thereto
09/02/2010US20100222285 Method of controlling the proliferation of vascular endothelial cells and inhibiting lumen formation
09/02/2010US20100222274 Glycosylation-deficient hepatocyte growth factor
09/02/2010US20100222258 TNF antagonist and TNF inhibitor containing it as an effective ingredient